Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy
Objective Lipoprotein glomerulopathy (LPG) is a rare disorder characterized by the development of glomerular lipoprotein thrombosis. LPG exhibits familial aggregation, with mutations in the apolipoprotein E (APOE) gene identified as the leading cause of this disease. This study aimed to investigate...
Main Authors: | Yan Qin, Xiao-Jing Sun, Yi-Fang Hu, Meng Jing, Xiao-Juan Yu, Ming-Hui Zhao, Ying Tan |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Renal Failure |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2024.2332491 |
Similar Items
-
Clinical and genetic analysis of lipoprotein glomerulopathy patients caused by APOE mutations
by: Mingxin Yang, et al.
Published: (2020-08-01) -
A case report of youth-onset lipoprotein glomerulopathy with APOE Chicago mutation
by: Yuhao Liu, et al.
Published: (2024-03-01) -
Lipoprotein Glomerulopathy, First Case Report from Canada
by: Ting JA, et al.
Published: (2022-06-01) -
Association between Lipoprotein(a) and diabetic nephropathy in patients with type 2 diabetes
by: Meng Li, et al.
Published: (2024-01-01) -
Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice
by: Hongyan Wu, et al.
Published: (2021-03-01)